Novo Nordisk A/S is a strong Danish pharmaceutical company headquartered in Bagsværd, Copenhagen. This article gives you a detailed overview of the company, elaborates on all influencing factors of this stock, and then gives an idea about the NVO stock forecast for upcoming years.
About The Novo Nordisk A/S (NYSE: NVO)
NOVO Nordisk was founded on Dec 21, 1923, this is a leading pharmaceutical company globally.
Novo Nordisk is managed by its major shareholding company, Novo Holdings A/S, which holds a 28% share of the company. Novo Nordisk manufactures and produces diabetes-related pharmaceutical products.
The main product of this company is the rug semaglutide which is used for the care of diabetes, this product is sold under the name of Ozempic and Rybelsus.
Novo Nordisk A/S Overview | |
Details | Information |
Stock Name | Novo Nordisk A/S |
Stock Symbol | NVO |
Stock Exchange | NYSE |
Market Cap | 288.48B USD |
Founder | Hans Christian Hagedorn, August Krogh |
Founded Year | 21 Dec 1923 |
Headquarter | Bagsværd, Copenhagen. Denmark |
Fundamentals of NVO Stock
This company’s market capitalization is 288.48B USD, and its average trading volume is 8.21M. Its yearly revenue growth is 31.26%, and its return on equity is 86.40%.
Company | Data |
AVG Volume | 8.21M |
Revenue Growth % (Yearly) | 31.26% |
Net Income in USD | 83.68B |
ROE | 86.40% |
EPS | 18.62 |
P/B Ratio | 3.79 |
P/E Ratio | – |
Dividend Yield | – |
Total Equity | 106.56B |
Net profit margin | 36.03 |
EBITDA Margin | 109.81B |
Effective tax rate | 20.05% |
History of the NVO Stock Price
NVO stock is listed on the New York Stock Exchange under the ticker symbol of NVO. NVO launched its initial public offering on 21 Dec 1984 and started from $0.12 per share.
After the year of 2009, this stock continuously touched the upper circuit. The highest stock price of NVO is $142.74, this price touched in 2024. You can see these price graphs in the above image.
Time | Per Share Value (USD) |
Previous Close | $83.07 |
Day Range | $78.17 – $80.88 |
Before 5D | $84.42 |
Before 1M | $105.96 |
Before 6M | $129.99 |
52 Week Range | $78.17 – $148.15 |
Before 1Y | $106.96 |
Before 5Y | $30.66 |
1 Feb 1985 | $0.12 |
All time Max | $142.74 |
Major Shareholder Of The NVO Stock
Novo Holdings A/S holds 28% share of this company which is the largest shareholder of NVO and you can see the remaining holding companies in the table below.
Shareholder | Share % |
Novo Holdings A/S (Investment Company) | 28% |
Novo Nordisk A/S | 0.65% |
State Street Global Advisors Ltd. | 0.21% |
Sjunde AP-fonden | 0.14% |
Eleva Capital SAS | 0.14% |
Coming 1 to 10-Year NVO Stock Forecast Price Chart
You can see a stock forecast of NVO for the upcoming 1 to 10 years in detail. In this chart, you can see the minimum and maximum stock value for the first half and second half respectively.
Year | Minimum & Maximum Per Stock Value (First term) | Minimum & Maximum Per Stock Value (second term) |
1 Year | $105.67 & $127.49 | $124.95 & $158.42 |
2 Year | $136.72 & $163.70 | $162.54 & $180.51 |
3 Year | $175.41 & $215.67 | $213.57 & $195.48 |
4 Year | $173.82 & $201.49 | $149.51 & $198.40 |
5 Year | $129.35 & $159.67 | $165.50 & $192.77 |
6 Year | $167.69 & $190.81 | $173.38 & $219.78 |
7 Year | $182.59 & $198.95 | $212.35 & $232.94 |
8 Year | $217.50 & $237.41 | $242.60 & $269.64 |
9 Year | $265.40 & $277.18 | $272.60 & $293.49 |
10 Year | $272.10 & $285.72 | $279.26 & $297.40 |
NVO Stock Forecast 2025
NVO stock forecast for 2025 is estimated to be $105.67 to $127.49 per share in the first half of the year. In the second half, this price could be hit up to $158.42 per share because of the sustainable growth of Ozempic and Wegovy.
2025 | Minimum Per Stock Price | Maximum per Stock Price |
First term | $105.67 | $127.49 |
Second term | $124.95 | $158.42 |
NVO Stock Forecast 2026
The stock price prediction of NVO for 2026 is clearly shown in the table which is $136.72 to $163.70 per share in the first half.
In the second half, this price reached $180.51 per share because of the innovative ideas of NOVO Nordisk in 2026.
2026 | Minimum Per Stock Price | Maximum per Stock Price |
First term | $136.72 | $163.70 |
Second term | $162.54 | $180.51 |
NVO Stock Forecast 2027
NVO stock price prediction for 2027 will be between $213.57 to $195.48. Obesity treatment of NOVO Nordisk attracts the entire market because the result of its products works like a panacea for Obesity.
2027 | Minimum Per Stock Price | Maximum per Stock Price |
First term | $175.41 | $215.67 |
Second term | $213.57 | $195.48 |
NVO Stock Forecast 2030
NVO stock forecast for 2030 is estimated to be $167.69 to $190.81 per share and its price will be reached at $219.78 in the second half.
2030 | Minimum Per Stock Price | Maximum per Stock Price |
First term | $167.69 | $190.81 |
Second term | $173.38 | $219.78 |
NVO Stock Forecast 2025 To 2040 Price Chart
NVO stock forecast for 2025 to 2040 is presented in the table below, you can take an idea from this predicted price. There are 4 different types of data available for a year.
Year | Minimum & Maximum Per Stock Value (First term) | Minimum & Maximum Per Stock Value (second term) |
2025 | $105.67 & $127.49 | $124.95 & $158.42 |
2026 | $136.72 & $163.70 | $162.54 & $180.51 |
2027 | $175.41 & $215.67 | $213.57 & $195.48 |
2028 | $173.82 & $201.49 | $149.51 & $198.40 |
2029 | $129.35 & $159.67 | $165.50 & $192.77 |
2030 | $167.69 & $190.81 | $173.38 & $219.78 |
2031 | $182.59 & $198.95 | $212.35 & $232.94 |
2032 | $217.50 & $237.41 | $242.60 & $269.64 |
2033 | $265.40 & $277.18 | $272.60 & $293.49 |
2034 | $272.10 & $285.72 | $279.26 & $297.40 |
2035 | $284.27 & $307.29 | $307.29 to $329.73 |
2040 | $392.18 & $402.76 | $398.74 & $429.71 |
Key Drivers for NVO Stock Growth
Several major key drivers for NVO stock will help the growth of NVO in the future.
Growing Demand for Diabetes Care: People face the problems of diabetes globally and the NOVO Nordisk products most effective in diabetes care such as Ozempic and Wegovy.
So if the demand for diabetes care increases in the future then the growth of this company is also increase.
Obesity Drug Market Expansion: Obesity drug market expansion is also helping the growth of NOVO Nordisk because its product Ozempic is successfully occupying the entire market in this sector.
Research and Development: NOVO continuously makes a huge investment in Research and Development so this also helps to produce new panacea products and then directly helps for the growth of this company.
2019 to 2023 Financial Chart of NVO Stock
If we take a look at the NVO stock yearly profit then we can see this company continuously generating profit in increasing ways. The profit of this company in 2023 was $83.68B which was an increase from $55.53B in 2022.
As you can see the profit of this company is increasing same as the revenue also increasing year by year. Last year revenue of this company was $232.26B which was an increase from $176.95B as previous year.
Year | Revenue Of NVO Stock | Profit of NVO Stock | Total Assets of NVO Stock |
2019 | $122.02B | $38.95B | $125.68B |
2020 | $126.95B | $42.14B | $144.92B |
2021 | $140.80B | $47.76B | $194.51B |
2022 | $176.95B | $55.53B | $241.26B |
2023 | $232.26B | $83.68B | $314.49B |
You Can Check – MARA Stock Forecast: Projections From 2025 To 2040
Challenges & Risk of NVO Stock
I explain the growth drivers of this stock but several challenges are also available and you must know about these challenges before investing in this stock.
Competition: Many times, you will see rivals launch products that directly impact the profit of already existing products. So competition is a big challenge and risk for the growth of NVO stock.
Economic Uncertainty: Currency fluctuations and the global economic downturn impact international sales and the result is growth of the company is as slow as previous growth.
R&D Failures: If the trial of research and development goes in the wrong way or continuously fails then this impact goes negative for the growth of NOVO Nordisk.
Conclusion
NOVO Nordisk has been a leading player in the field of diabetes care for the past years and also successfully dominated this field. So for long-term investment, this stock can be profitable.
However, there are many types of challenges and risks also available but NVO has much potential and it will tackle these challenges easily in the future.
FAQs
What is the stock price prediction for NVO in 2025?
The stock price prediction for NVO in 2025 will be $124.95 & $158.42.
What is the target price for NVO stock?
The target price for NVO stock in the last of 2025 is expected to reach at $158.42 per share.
What are the major growth drivers for NVO stock?
The demand for diabetes care is the major growth driver for NVO stock because NOVO products are dominating diabetes at the global level.
Can NVO stock reach $300 by 2035?
Yes, according to the present market trends and business growth, analysts predict that NVO stock hit $307.29 to $329.73 per share in the year 2035.
What risks should investors consider before investing in NVO?
There are several risks involved like regulatory challenges, economic downturn, and the competition are also high in this industry.